THE PLASMA DISAPPEARANCE TIME AND CATABOLIC HALF-LIFE OF I¹³¹-LABELED NORMAL HUMAN GAMMA GLOBULIN IN AMYLOIDOSIS AND IN RHEUMATOID ARTHRITIS

Department of Medicine, Harvard Medical School, and the Massachusetts General Hospital, Boston, Mass.

This is publication no. 298 of the Robert W. Lovett Memorial Unit for the Study of Crippling Disease, Harvard Medical School, at the Massachusetts General Hospital. Grants in support of these investigations were received from the National Institute of Arthritis and Metabolic Diseases, nos. A-1064 and A-2123, and from an Institutional Grant from the American Cancer Society (In-42), and the Eli Lilly Company.

Find articles by Mills, J. in: JCI | PubMed | Google Scholar

Department of Medicine, Harvard Medical School, and the Massachusetts General Hospital, Boston, Mass.

This is publication no. 298 of the Robert W. Lovett Memorial Unit for the Study of Crippling Disease, Harvard Medical School, at the Massachusetts General Hospital. Grants in support of these investigations were received from the National Institute of Arthritis and Metabolic Diseases, nos. A-1064 and A-2123, and from an Institutional Grant from the American Cancer Society (In-42), and the Eli Lilly Company.

Find articles by Calkins, E. in: JCI | PubMed | Google Scholar

Department of Medicine, Harvard Medical School, and the Massachusetts General Hospital, Boston, Mass.

This is publication no. 298 of the Robert W. Lovett Memorial Unit for the Study of Crippling Disease, Harvard Medical School, at the Massachusetts General Hospital. Grants in support of these investigations were received from the National Institute of Arthritis and Metabolic Diseases, nos. A-1064 and A-2123, and from an Institutional Grant from the American Cancer Society (In-42), and the Eli Lilly Company.

Find articles by Cohen, A. in: JCI | PubMed | Google Scholar